UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

Long-Term Entecavir Treatment Results in Sustained Antiviral Efficacy and Prolonged Life Span in the Woodchuck Model of Chronic Hepatitis Infection

The Journal of infectious diseases, 2001-11, Vol.184 (10), p.1236-1245

2001

Volltextzugriff (PDF)

Orally Active Fusion Inhibitor of Respiratory Syncytial Virus

Antimicrobial Agents and Chemotherapy, 2004-02, Vol.48 (2), p.413-422

2004

Volltextzugriff (PDF)

Oral Efficacy of a Respiratory Syncytial Virus Inhibitor in Rodent Models of Infection

Antimicrobial Agents and Chemotherapy, 2004-07, Vol.48 (7), p.2448-2454

2004

Volltextzugriff (PDF)

Efficacy of the Carbocyclic 2′-Deoxyguanosine Nucleoside BMS-200475 in the Woodchuck Model of Hepatitis B Virus Infection

Antimicrobial Agents and Chemotherapy, 1998-12, Vol.42 (12), p.3209-3217

1998

Volltextzugriff (PDF)

Can we compare lichen diversity data? A test with skilled teams

Ecological indicators, 2012-12, Vol.23, p.509-516

2012

Volltextzugriff (PDF)

P-54 Circulating immune cells as a tool to predict benefit from atezolizumab/bevacizumab in advanced hepatocellular carcinoma (aHCC)

Annals of oncology, 2023-06, Vol.34, p.S32-S32

2023

Volltextzugriff (PDF)

P-402 Six-months CA19.9 velocity as a predictive factor for relapse-free survival after curative pancreasectomy in pancreatic cancer

Annals of oncology, 2023-06, Vol.34, p.S154-S154

2023

Volltextzugriff (PDF)

381P Evaluation of the prognostic impact of circulating free tumor DNA (cftDNA) dynamics in borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC)

Annals of oncology, 2024-06, Vol.35, p.S154-S154

2024

Volltextzugriff (PDF)

185P The combined role of patients (pts) gender and disease etiology on unresectable HCC (uHCC) first-line (1L) treatment outcome

Annals of oncology, 2024-06, Vol.35, p.S83-S83

2024

Volltextzugriff (PDF)

P-173 Extended molecular profiling in patients with biliary tract cancers: Impact of the BRCAness phenotype in patients management

Annals of oncology, 2023-06, Vol.34, p.S77-S77

2023

Volltextzugriff (PDF)

SO-13 Outcomes and a prognostic classifier in 130 patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade

Annals of oncology, 2023-06, Vol.34, p.S167-S167

2023

Volltextzugriff (PDF)

292P Extended molecular profiling (EMP) and access to targeted treatment (TT) in advanced biliary tract cancer (BTC): Results from the Italian cholangiocarcinoma dataset (ANITA)

Annals of oncology, 2024-06, Vol.35, p.S123-S123

2024

Volltextzugriff (PDF)

Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (5), p.1115-1122

2006

Volltextzugriff (PDF)

300P Prognostic and predictive role of FGFR2 and IDH1 targetable alterations in advanced biliary tract cancer (aBTC): Data from the Italian ANITA dataset

Annals of oncology, 2024-06, Vol.35, p.S127-S127

2024

Volltextzugriff (PDF)

P-169 Early-onset biliary tract cancer: An overview of clinical presentation, risk factors, molecular profile and outcome in a multicentric Italian cohort

Annals of oncology, 2023-06, Vol.34, p.S75-S76

2023

Volltextzugriff (PDF)

PD-17 Multicentric prospective study assessing clinical benefit of targeted treatment for patients with biliary tract cancers

Annals of oncology, 2023-06, Vol.34, p.S7-S8

2023

Volltextzugriff (PDF)

SO-3 Clinical relevance and actionability of BRAF alterations in advanced biliary tract cancer: Preliminary results from the multicenter B-REAL study

Annals of oncology, 2023-06, Vol.34, p.S162-S163

2023

Volltextzugriff (PDF)

Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (16), p.4857-4862

2009

Volltextzugriff (PDF)

Concordance of PD-L1 status in primary gastroesophageal adenocarcinoma and matched peritoneal metastases: a single institution study

ESMO Gastrointestinal Oncology, 2024-09, Vol.5, Article 100089

2024

Volltextzugriff (PDF)

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (4), p.895-901

2007

Volltextzugriff (PDF)

Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck ( Marmota monax) model of chronic hepatitis B virus (HBV) infection

Antiviral research, 2000-12, Vol.48 (3), p.197-203

2000

Volltextzugriff (PDF)

Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety

Bioorganic & medicinal chemistry letters, 2007-09, Vol.17 (17), p.4784-4790

2007

Volltextzugriff (PDF)

Effect of macrophage-specific colony-stimulating factor (CSF-1) on swine monocyte/macrophage susceptibility to in vitro infection by African swine fever virus

Veterinary microbiology, 1990, Vol.25 (2), p.153-176

1990

Volltextzugriff (PDF)

Susceptibility of Inbred Syrian Golden Hamsters (Mesocricetus auratus) to Lethal Disease by Lymphocytic Choriomeningitis Virus

Proceedings of the Society for Experimental Biology and Medicine, 1987-07, Vol.185 (3), p.250-261

1987

Volltextzugriff (PDF)

Moderately virulent African swine fever virus infection: blood cell changes and infective virus distribution among blood components

American journal of veterinary research, 1988-03, Vol.49 (3), p.338

1988

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Life Sciences & Biomedicine
(56)
Humans
(45)
Animals
(36)
Female
(29)
Biological And Medical Sciences
(28)
Medical Sciences
(23)
Male
(22)
Aged
(19)
Middle Aged
(19)
Mice
(17)
Cardiovascular System & Cardiology
(15)
Radiology, Nuclear Medicine & Medical Imaging
(13)
Cardiac & Cardiovascular Systems
(12)
Adult
(11)
Oncology
(11)
Pharmacology. Drug Treatments
(11)
Aged, 80 And Over
(10)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(10)
Antiviral Agents
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Long-Term Entecavir Treatment Results in Sustained Antiviral Efficacy and Prolonged Life Span in the Woodchuck Model of Chronic Hepatitis Infection

Orally Active Fusion Inhibitor of Respiratory Syncytial Virus

Oral Efficacy of a Respiratory Syncytial Virus Inhibitor in Rodent Models of Infection

Efficacy of the Carbocyclic 2′-Deoxyguanosine Nucleoside BMS-200475 in the Woodchuck Model of Hepatitis B Virus Infection

Can we compare lichen diversity data? A test with skilled teams

P-54 Circulating immune cells as a tool to predict benefit from atezolizumab/bevacizumab in advanced hepatocellular carcinoma (aHCC)

P-402 Six-months CA19.9 velocity as a predictive factor for relapse-free survival after curative pancreasectomy in pancreatic cancer

381P Evaluation of the prognostic impact of circulating free tumor DNA (cftDNA) dynamics in borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC)

185P The combined role of patients (pts) gender and disease etiology on unresectable HCC (uHCC) first-line (1L) treatment outcome

P-173 Extended molecular profiling in patients with biliary tract cancers: Impact of the BRCAness phenotype in patients management

SO-13 Outcomes and a prognostic classifier in 130 patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade

292P Extended molecular profiling (EMP) and access to targeted treatment (TT) in advanced biliary tract cancer (BTC): Results from the Italian cholangiocarcinoma dataset (ANITA)

Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo

300P Prognostic and predictive role of FGFR2 and IDH1 targetable alterations in advanced biliary tract cancer (aBTC): Data from the Italian ANITA dataset

P-169 Early-onset biliary tract cancer: An overview of clinical presentation, risk factors, molecular profile and outcome in a multicentric Italian cohort

PD-17 Multicentric prospective study assessing clinical benefit of targeted treatment for patients with biliary tract cancers

SO-3 Clinical relevance and actionability of BRAF alterations in advanced biliary tract cancer: Preliminary results from the multicenter B-REAL study

Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo

Concordance of PD-L1 status in primary gastroesophageal adenocarcinoma and matched peritoneal metastases: a single institution study

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck ( Marmota monax) model of chronic hepatitis B virus (HBV) infection

Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety

Effect of macrophage-specific colony-stimulating factor (CSF-1) on swine monocyte/macrophage susceptibility to in vitro infection by African swine fever virus

Susceptibility of Inbred Syrian Golden Hamsters (Mesocricetus auratus) to Lethal Disease by Lymphocytic Choriomeningitis Virus

Moderately virulent African swine fever virus infection: blood cell changes and infective virus distribution among blood components

Suchergebnisse filtern